Membrane estrogen receptor engagement activates endothelial nitric oxide synthase via the PI3-kinase-Akt pathway in human endothelial cells - PubMed (original) (raw)
Membrane estrogen receptor engagement activates endothelial nitric oxide synthase via the PI3-kinase-Akt pathway in human endothelial cells
M P Haynes et al. Circ Res. 2000.
Abstract
17beta-Estradiol (E(2)) is a rapid activator of endothelial nitric oxide synthase (eNOS). The product of this activation event, NO, is a fundamental determinant of cardiovascular homeostasis. We previously demonstrated that E(2)-stimulated endothelial NO release can occur without an increase in cytosolic Ca(2+). Here we demonstrate for the first time, to our knowledge, that E(2) rapidly induces phosphorylation and activation of eNOS through the phosphatidylinositol 3 (PI3)-kinase-Akt pathway. E(2) treatment (10 ng/mL) of the human endothelial cell line, EA.hy926, resulted in increased NO production, which was abrogated by the PI3-kinase inhibitor, LY294002, and the estrogen receptor antagonist ICI 182, 780. E(2) stimulated rapid Akt phosphorylation on serine 473. As has been shown for vascular endothelial growth factor, eNOS is an E(2)-activated Akt substrate, demonstrated by rapid eNOS phosphorylation on serine 1177, a critical residue for eNOS activation and enhanced sensitivity to resting cellular Ca(2+) levels. Adenoviral-mediated EA.hy926 transduction confirmed functional involvement of Akt, because a kinase-deficient, dominant-negative Akt abolished E(2)-stimulated NO release. The membrane-impermeant E(2)BSA conjugate, shown to bind endothelial cell membrane sites, also induced rapid Akt and consequent eNOS phosphorylation. Thus, engagement of membrane estrogen receptors results in rapid endothelial NO release through a PI3-kinase-Akt-dependent pathway. This explains, in part, the reduced requirement for cytosolic Ca(2+) fluxes and describes an important pathway relevant to cardiovascular pathophysiology.
Comment in
- Nongenomic, ER-mediated activation of endothelial nitric oxide synthase: how does it work? What does it mean?
Mendelsohn ME. Mendelsohn ME. Circ Res. 2000 Nov 24;87(11):956-60. doi: 10.1161/01.res.87.11.956. Circ Res. 2000. PMID: 11090536 Review.
Similar articles
- Src kinase mediates phosphatidylinositol 3-kinase/Akt-dependent rapid endothelial nitric-oxide synthase activation by estrogen.
Haynes MP, Li L, Sinha D, Russell KS, Hisamoto K, Baron R, Collinge M, Sessa WC, Bender JR. Haynes MP, et al. J Biol Chem. 2003 Jan 24;278(4):2118-23. doi: 10.1074/jbc.M210828200. Epub 2002 Nov 12. J Biol Chem. 2003. PMID: 12431978 - Estrogen receptor activation of phosphoinositide-3 kinase, akt, and nitric oxide signaling in cerebral blood vessels: rapid and long-term effects.
Stirone C, Boroujerdi A, Duckles SP, Krause DN. Stirone C, et al. Mol Pharmacol. 2005 Jan;67(1):105-13. doi: 10.1124/mol.104.004465. Epub 2004 Oct 20. Mol Pharmacol. 2005. PMID: 15496504 - Rapid activation of endothelial NO synthase by estrogen: evidence for a steroid receptor fast-action complex (SRFC) in caveolae.
Chambliss KL, Shaul PW. Chambliss KL, et al. Steroids. 2002 May;67(6):413-9. doi: 10.1016/s0039-128x(01)00177-5. Steroids. 2002. PMID: 11960616 Review. - Vascular cell signaling by membrane estrogen receptors.
Kim KH, Moriarty K, Bender JR. Kim KH, et al. Steroids. 2008 Oct;73(9-10):864-9. doi: 10.1016/j.steroids.2008.01.008. Epub 2008 Jan 18. Steroids. 2008. PMID: 18325557 Free PMC article. Review.
Cited by
- Impact of Secondary Amenorrhea on Cardiovascular Disease Risk in Physically Active Women: A Systematic Review and Meta-Analysis.
Tegg NL, Myburgh C, O'Donnell E, Kennedy M, Norris CM. Tegg NL, et al. J Am Heart Assoc. 2024 Mar 19;13(6):e033154. doi: 10.1161/JAHA.123.033154. Epub 2024 Mar 18. J Am Heart Assoc. 2024. PMID: 38497482 Free PMC article. - Effect of fasting glucose levels on carotid intima-media thickness in premenopausal versus postmenopausal women.
Xia R, Fan S, Jian H, Lei C, Wendan M, Chenxu W, Yicheng F, Tavengana G, Mingfei J, Huan W, Wendan M, Yufeng W. Xia R, et al. Arch Endocrinol Metab. 2024 Mar 7;68:e230110. doi: 10.20945/2359-4292-2023-0110. Arch Endocrinol Metab. 2024. PMID: 38456951 Free PMC article. - Oestrogen receptor-independent actions of oestrogen in cancer.
Gopinath P, Oviya RP, Gopisetty G. Gopinath P, et al. Mol Biol Rep. 2023 Nov;50(11):9497-9509. doi: 10.1007/s11033-023-08793-8. Epub 2023 Sep 20. Mol Biol Rep. 2023. PMID: 37731028 Review. - Gender-based research underscores sex differences in biological processes, clinical disorders and pharmacological interventions.
Bernstein SR, Kelleher C, Khalil RA. Bernstein SR, et al. Biochem Pharmacol. 2023 Sep;215:115737. doi: 10.1016/j.bcp.2023.115737. Epub 2023 Aug 6. Biochem Pharmacol. 2023. PMID: 37549793 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous